Sumitomo Mitsui DS Asset Management Company Ltd Buys 162 Shares of Waters Co. (NYSE:WAT)

Sumitomo Mitsui DS Asset Management Company Ltd lifted its position in Waters Co. (NYSE:WAT) by 2.6% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 6,412 shares of the medical instruments supplier’s stock after purchasing an additional 162 shares during the quarter. Sumitomo Mitsui DS Asset Management Company Ltd’s holdings in Waters were worth $2,379,000 at the end of the most recent reporting period.

Other hedge funds have also made changes to their positions in the company. Kennebec Savings Bank bought a new position in Waters in the 3rd quarter valued at $33,000. Fortitude Family Office LLC increased its stake in shares of Waters by 235.7% in the fourth quarter. Fortitude Family Office LLC now owns 94 shares of the medical instruments supplier’s stock valued at $35,000 after buying an additional 66 shares in the last quarter. Ashton Thomas Securities LLC bought a new position in shares of Waters in the third quarter valued at about $35,000. R Squared Ltd acquired a new position in Waters during the 4th quarter worth about $63,000. Finally, Itau Unibanco Holding S.A. lifted its position in Waters by 63.2% during the 3rd quarter. Itau Unibanco Holding S.A. now owns 186 shares of the medical instruments supplier’s stock worth $67,000 after buying an additional 72 shares in the last quarter. Institutional investors and hedge funds own 94.01% of the company’s stock.

Waters Stock Performance

Shares of NYSE:WAT opened at $407.61 on Tuesday. The firm’s 50 day simple moving average is $389.98 and its 200 day simple moving average is $363.11. Waters Co. has a fifty-two week low of $279.24 and a fifty-two week high of $423.56. The company has a market capitalization of $24.20 billion, a price-to-earnings ratio of 38.89, a P/E/G ratio of 7.37 and a beta of 1.01. The company has a debt-to-equity ratio of 1.14, a current ratio of 2.02 and a quick ratio of 1.38.

Wall Street Analyst Weigh In

WAT has been the subject of several research reports. Stifel Nicolaus raised their price objective on shares of Waters from $332.00 to $360.00 and gave the company a “hold” rating in a research report on Monday, November 4th. Barclays raised shares of Waters from an “underweight” rating to an “equal weight” rating and raised their price target for the company from $360.00 to $415.00 in a report on Monday. Sanford C. Bernstein upgraded Waters from a “market perform” rating to an “outperform” rating and set a $430.00 price objective on the stock in a research report on Friday, January 10th. Cfra set a $389.00 target price on Waters in a research report on Thursday, October 17th. Finally, TD Cowen raised their price target on Waters from $363.00 to $410.00 and gave the company a “hold” rating in a report on Monday, November 4th. Ten analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Hold” and an average price target of $388.64.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.